logo

VANI

Vivani MedicalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About VANI

Vivani Medical, Inc.

A clinical stage company, develops various implants that treat chronic diseases with high unmet medical need

Pharmaceutical
12/17/2009
11/19/2014
NASDAQ Stock Exchange
36
12-31
Common stock
1350 S. Loop Road, Alameda, CA 94502
--
Vivani Medical, Inc., was incorporated under the laws of the State of California on December 17, 2009. Vivani Medical, Inc., a preclinical stage biopharmaceutical company, utilizes its proprietary nano-portal technology to develop miniaturized subcutaneous implants for long-term, near-constant rate delivery of multiple drugs for the treatment of chronic diseases.

Company Financials

EPS

VANI has released its 2025 Q3 earnings. EPS was reported at -0.11, versus the expected -0.11, meeting expectations. The chart below visualizes how VANI has performed over recent quarters, highlighting trends in earnings surprises.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime